Literature DB >> 19877369

Bortezomib and restoration of chemosensitivity.

Alessandro Gozzetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19877369     DOI： 10.1038/nrclinonc.2009.15-c1

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

1.  Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myeloma.

Authors:  James R Berenson; Sundar Jagannath; Bart Barlogie; David T Siegel; Raymond Alexanian; Paul G Richardson; David Irwin; Melissa Alsina; S Vincent Rajkumar; Gordon Srkalovic; Seema Singhal; Steven Limentani; Ruben Niesvizky; Dixie L Esseltine; Elizabeth Trehu; David P Schenkein; Kenneth Anderson
Journal:  Cancer       Date:  2005-11-15       Impact factor: 6.860

2.  Restoration of chemosensitivity by bortezomib: implications for refractory myeloma.

Authors:  Chor Sang Chim; Yu Yan Hwang; Clara Pang; Tony W Shek
Journal:  Nat Rev Clin Oncol       Date:  2009-04       Impact factor: 66.675
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.